|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/14 | |
| A61P 31/18 | |||
| A61P 35/00 |
| (11) | Number of the document | 2694088 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12768091.6 |
| Date of filing the European patent application | 2012-04-05 | |
| (97) | Date of publication of the European application | 2014-02-12 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2012/000159 |
| Date | 2012-04-05 |
| (87) | Number | WO 2012/137199 |
| Date | 2012-10-11 |
| (30) | Number | Date | Country code |
| 201161472642 P | 2011-04-07 | US |
| (72) |
YAMAMOTO, Nobuto, US
|
| (73) |
Efranat Ltd.,
7 Openhiemer Street, 76701 Rehovot,
IL
|
| (54) | MACROPHAGE ACTIVATING FACTOR FOR PHARMACEUTICAL COMPOSITIONS |
| MACROPHAGE ACTIVATING FACTOR FOR PHARMACEUTICAL COMPOSITIONS |